본문 바로가기
KERD
논문KCI 등재

Telomerase Activity is Constitutively Expressed in the Murine CD8+ T Cells and Controlled Transcriptionally and Post-Translationally

김소정|김미형|김길현
대한면역학회 (The Korean Association of Immunologists)|2004.09|Immune Network|제4권 제3호|pp. 166-175

0

조회

0

다운로드

0

인용

0

참고문헌

초록

Abstract

Background: Telomerase, a ribonucleoprotein enzyme capable of synthesizing telomeric repeats, attracts attention for its possible role in determining the replicative capacity of normal somatic cells, transformed cells, and cells of the germline lineage. Differently from normal somatic cells with no telomerase activity, normal lymphocytes has been reported to have telomerase activity comparable to that found in transformed cells during development and activation, which substantiate a role in supporting the capacity of lymphocytes for extensive clonal expansion. Methods: Here, in order to define the telomerase regulation in murine T lymphocytes, telomerase activity in cloned murine CD8 T cells and na ve CD8 T cells isolated from C57BL/6 mice was examined. Next, the regulatory mechanism of telomerase activity at transcriptional and post- translational levels was investigated by determining the expression level of the TERT protein, a key component for telomerase activity. Results: It was demonstrated that telomerase activity was expressed in an inactivated state as well as in an activated state in the murine CD8 T lymphocytes by using TRAP assay. The increase of telomerase activity was partially dependent on the net increase of TERT expression. Also, telomerase activity was decreased after treatment with protein kinase inhibitors, indicating that telomerase activation was prevented by inhibition of phosphorylation. Conclusion: Therefore, these results suggest that telomerase activity is constitutively expressed in the murine resting T lymphocytes and controlled by both transcriptional regulation and post-translational modifications. (Immune Network 2004;4(3):166-175)

참고문헌 (31)

  1. "Telomerases", 61, pp.113~131 (1992)
  2. "Telomeres and telomerase in aging and cancer", 5, pp.249~256 (1995)
  3. "Structure and function of telomeres", 350, pp.569~571 (1991)
  4. "Telomeres shorten during ageing of human fibroblasts", 345, pp.458~460 (1990)
  5. "Studies of the molecular machnisms in the regulation of telomerase activity", 13, pp.2091~2104 (1999)
  6. "Complex regulation of telomerase activity", 159, pp.405~410 (2001)
  7. "Regulation of telomerase RNA template expression in human T lymphocyte development and activation", 158, pp.3215~3220 (1997)
  8. "The telomerase reverse trandcriptase is limiting and necessary for telomerase function in vivo", 10, pp.1459~1462 (2000)
  9. "Constitutive and regulated expression of telomerase reverse trascriptase(hTERT) in human lymphocytes", 96, pp.5147~5152 (1999)
  10. "Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8 T lymphocyte immortalization", 165, pp.4978~4984 (2000)
  11. "Immortalization of human CD8 T cell clones by ectopic expression of telomerase reverse transcriptase", 165, pp.4239~4245 (2000)
  12. "Telomerase is controlled by protein kinase Cα in human breast cancer cells", 273, pp.33436~33442 (1998)
  13. "Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit", 274, pp.13085~13090 (1999)
  14. "Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells", 272, pp.16729~16732 (1997)
  15. "Telomerase activation in human T lymphocytes does not require increase in telomerase reverse trascriptase protein but is associated with hTERT phosphorylation and nuclear translocation", 166, pp.4826~4830 (2001)
  16. "T-cell subset relationships in thymocyte development", 3, pp.204~209 (1991)
  17. "Selective events in T cell development", 12, pp.675~705 (1994)
  18. "Replicative senescence of T cells does the Hayflick Limit lead to immune exhaustion", 18, pp.450~454 (1997)
  19. "Regulation of telomere length and telomerase in T and B cells a mechanism for maintaining replicative potential", 9, pp.151~157 (1998)
  20. "Tales of tails regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging", 160, pp.43~54 (1997)
  21. "A tale of ends", 403, pp.149~151 (2000)
  22. "Mechanism of telomerase induction during T cell activation", 228, pp.58~64 (1996)
  23. "Regulated expression of telomerase activity in human T lymphocyte development and activation", 183, pp.2471~2479 (1996)
  24. "Activation of telomerase in human lymphocytes and hematopoietic progenitor cells", 155, pp.3711~3715 (1995)
  25. "Shortened telomeres in clonally expanded CD28 CD8 T cells imply a replicative history that is distinct from their CD28 CD8 counterparts", 156, pp.3587~3590 (1996)
  26. "Human naive and memory T lymphocytes differ in telomeric length and replicative potential", 92, pp.11091~11094 (1995)
  27. "Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).", 25, pp.2595~2597 (1997)
  28. "Specific association of human telomerase activity with immortal cells and cancer", 266, pp.2011~2015 (1994)
  29. "Mechanisms regulating telomerase activity in murine T cells", 158, pp.622~628 (1997)
  30. "Antigen-dependent regulation of telomerase activity in murine T cells", 160, pp.5702~5706 (1998)
  31. "Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen", 342, pp.559~61 (1989)

이 간행물의 다른 논문 (7건)

면역보조제의 작용 및 개발손은수, 손은화, 표석능pp. 131-142Differential Signaling via Tumor Necrosis Factor-Associated Factors (TRAFs) by CD27 and CD40 in Mouse B Cells박혜경, 우소연, Gail A. Bishoppp. 143-154B세포의 증식에 있어 B-1 임파구와 B-2 임파구의 차이점에 대한 연구조중생, Thomas L. Rothstein, 여승근, 박동춘pp. 155-160Anti-cardiolipin 항체와 Cardiolipin의 결합에 미치는 β2-GP1의 영향장영주, 강은영pp. 161-165Disodium Kromoglycate와 Ketotifen의 사람정장 유도 비만세포 활성화 억제작용채옥희pp. 176-183
원문 보기